CareLit · DOI-Nachweis · Klinische Pädiatrie
Targeting differentially expressed histone deacetylases in Medulloblastoma – novel approach for treatment of high risk patients
DOI 10.1055/s-0033-1353458
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Ecker, I Oehme, A Schomburg, R Mazitschek, A Korshunov, M Kool, M Lodrini, HE Deubzer, A von Deimling, AE Kulozik, S Pfister, O Witt, T Milde
ZeitschriftKlinische Pädiatrie
Ausgabe11/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Medulloblastoma (MB) is the most common malignant brain tumor in children. According to the current consensus MB comprises 4 different molecular subgroups with highly variable clinical courses. In particular patients with Group 3 tumors show poor overall survival despite multimodal treatment, and novel treatment strategies are urgently needed. Histone deacetylase (HDAC) expression levels are frequently…
Zitieren
Zitierempfehlung
J Ecker, I Oehme, A Schomburg, R Mazitschek, A Korshunov, M Kool, M Lodrini, HE Deubzer, A von Deimling, AE Kulozik, S Pfister, O Witt, T Milde (2013) Targeting differentially expressed histone deacetylases in Medulloblastoma – novel approach for treatment of high risk patients. Klinische Pädiatrie (11). https://doi.org/10.1055/s-0033-1353458
Mit CareLit weiterarbeiten